{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:12:34Z","timestamp":1762866754307,"version":"3.37.3"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"CONACYT","doi-asserted-by":"publisher","award":["220224"],"award-info":[{"award-number":["220224"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Science and Engineering: C"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.msec.2016.01.015","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T03:15:25Z","timestamp":1452136525000},"page":"801-808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Synthesis and characterization of a HAp-based biomarker with controlled drug release for breast cancer"],"prefix":"10.1016","volume":"61","author":[{"given":"Maykel","family":"Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulises","family":"Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Quintanilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogelio","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msec.2016.01.015_bb0005","doi-asserted-by":"crossref","first-page":"8726","DOI":"10.1016\/j.biomaterials.2013.07.092","article-title":"Controlled release of cisplatin from pH-thermal dual responsive nanogels","volume":"34","author":"Peng","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.msec.2016.01.015_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.phrs.2014.12.006","article-title":"Enhancement of vascular endothelial growth factor release in long-term drug-treated breast cancer via transient receptor potential channel 5-Ca2+-hypoxia-inducible factor 1\u03b1 pathway","volume":"93","author":"Zhu","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.msec.2016.01.015_bb0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbamem.2004.03.006","article-title":"Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer","volume":"1663","author":"Charrois","year":"2004","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.msec.2016.01.015_bb0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.addr.2012.08.012","article-title":"Polymer therapeutics-prospects for 21st century: the end of the beginning","volume":"65","author":"Duncan","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.msec.2016.01.015_bb0025","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijpharm.2014.10.039","article-title":"Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading","volume":"477","author":"Li","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2016.01.015_bb0030","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0959-8049(00)00133-7","article-title":"Achievements and future of chemotherapy","volume":"36","author":"Verweij","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.msec.2016.01.015_bb0035","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0960-9776(07)70010-3","article-title":"Chemotherapy \u2014 overview and future perspectives","volume":"15","author":"Aebi","year":"2006","journal-title":"Breast"},{"key":"10.1016\/j.msec.2016.01.015_bb0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cacc.2008.01.004","article-title":"The side effects of chemotherapeutic agents","volume":"19","author":"Carr","year":"2008","journal-title":"Curr. Anaesth. Crit. Care"},{"key":"10.1016\/j.msec.2016.01.015_bb0045","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jiac.2015.03.008","article-title":"Early measurement of urinary N-acetyl-\u03b2-glucosaminidase helps predict severe hyponatremia associated with cisplatin-containing chemotherapy","volume":"21","author":"Arakawa","year":"2015","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.msec.2016.01.015_bb0050","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.msec.2016.01.015_bb0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1369-7021(11)70058-X","article-title":"Biomaterials & scaffolds for tissue engineering","volume":"14","author":"O'Brien","year":"2011","journal-title":"Mater. Today"},{"key":"10.1016\/j.msec.2016.01.015_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cej.2013.02.037","article-title":"Strontium substituted hydroxyapatite porous microspheres: surfactant-free hydrothermal synthesis, enhanced biological response and sustained drug release","volume":"222","author":"Lin","year":"2013","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.msec.2016.01.015_bb0065","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jnoncrysol.2007.06.100","article-title":"Thirty-five years of guided tissue engineering","volume":"354","author":"Karlsson","year":"2008","journal-title":"J. Non-Cryst. Solids"},{"key":"10.1016\/j.msec.2016.01.015_bb0070","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.1016\/j.actbio.2013.04.012","article-title":"Synthesis methods for nanosized hydroxyapatite with diverse structures","volume":"9","author":"Sadat-Shojai","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.msec.2016.01.015_bb0075","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1007\/s10856-007-3346-5","article-title":"Porous ceramic bone scaffolds for vascularized bone tissue regeneration","volume":"19","author":"Will","year":"2008","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.msec.2016.01.015_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1063\/1.3576926","article-title":"Perfusion systems that minimize vascular volume fraction in engineered tissues","volume":"5","author":"Truslow","year":"2011","journal-title":"Biomicrofluidics"},{"key":"10.1016\/j.msec.2016.01.015_bb0085","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1557\/JMR.2008.0191","article-title":"Porous hydroxyapatite-based obturation materials for dentistry","volume":"23","author":"Brostow","year":"2008","journal-title":"J. Mater. Res."},{"key":"10.1016\/j.msec.2016.01.015_bb0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-0248(99)00793-9","article-title":"Synthesis of a new hydroxyapatite\u2013silica composite material","volume":"211","author":"Villacampa","year":"2000","journal-title":"J. Cryst. Growth"},{"key":"10.1016\/j.msec.2016.01.015_bb0095","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.actbio.2007.11.003","article-title":"Mesoporous silica\/apatite nanocomposite: special synthesis route to control local drug delivery","volume":"4","author":"Sousa","year":"2008","journal-title":"Acta Biomater."},{"key":"10.1016\/j.msec.2016.01.015_bb0100","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.actbio.2013.10.036","article-title":"Significance of calcium phosphate coatings for the enhancement of new bone osteogenesis \u2014 a review","volume":"10","author":"Surmenev","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.msec.2016.01.015_bb0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cplett.2004.12.096","article-title":"The prediction of Raman spectra of platinum(II) anticancer drugs by density functional theory","volume":"403","author":"Michalska","year":"2005","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.msec.2016.01.015_bb0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.chemphys.2007.01.002","article-title":"Electronic structure and vibrational spectra of cis-diammine(orotato)platinum(II), a potential cisplatin analogue: DFT and experimental study","volume":"333","author":"Wysoki\u0144ski","year":"2007","journal-title":"Chem. Phys."},{"key":"10.1016\/j.msec.2016.01.015_bb0115","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ica.2008.04.024","article-title":"Molecular origin of the sequence-dependent kinetics of reactions between cisplatin derivatives and DNA","volume":"362","author":"Kozelka","year":"2009","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.msec.2016.01.015_bb0120","first-page":"3","article-title":"Hydrolysis products of cisplatin: pK, determinations via [IH, 15N] NMR spectroscopy","author":"J.D.R.P.J.S.","year":"1992","journal-title":"J. Chem. Soc. Chem. Commun."}],"container-title":["Materials Science and Engineering: C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493116300133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493116300133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T21:28:25Z","timestamp":1572730105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928493116300133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":24,"alternative-id":["S0928493116300133"],"URL":"https:\/\/doi.org\/10.1016\/j.msec.2016.01.015","relation":{},"ISSN":["0928-4931"],"issn-type":[{"type":"print","value":"0928-4931"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and characterization of a HAp-based biomarker with controlled drug release for breast cancer","name":"articletitle","label":"Article Title"},{"value":"Materials Science and Engineering: C","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msec.2016.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}